November 17, 2014
Predicting adverse drug reactions in patients with Multiple Sclerosis
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
The third annual Neuromyelitis Optica (NMO) Information Day will be held at the Djavad Mowafaghian Centre...
Molecular geneticist Dr. Carles Vilarino-Guell has played an important role in the identification of...
Amyotophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating and...
A study led by Dr. Neil Cashman and his research team affiliated with the...